3 completed. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Cancer of Cervix: new trials by email Literature Review of Cancer of Cervix trials Research Report on Cancer of Cervix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study Gardasil® [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant vaccine], Two dose, Control group - Cancer of Cervix | Phase 2 / Phase 3 | Completed | Instituto Nacional de Salud Publica, Mexico | 6000 | 2018-05-30 | 2021-12-08 |
| Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer DPX-E7 vaccine, Cyclophosphamide - Cancer of Head and Neck, Cancer of Cervix | Phase 1 / Phase 2 | Completed | Dana-Farber Cancer Institute | 11 | 2017-03-30 | 2024-01-11 |
| Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients gemcitabine, cisplatin, chemoradiation - Cancer of Cervix | Phase 2 | Completed | Professor Fernando Figueira Integral Medicine Institute | 50 | 2013-09-01 | 2015-10-16 |
Uterine Cervical Neoplasms (3) · Anus Neoplasms (1) · Head and Neck Neoplasms (1) · Neoplasms (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Neoplasms by Site (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Uterine Cervical Diseases (3) · Uterine Diseases (3) · Uterine Neoplasms (3) · Neoplasms (2) · Anus Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1)
Chemoradiotherapy (1) · Cisplatin (1) · Control Groups (1) · Cyclophosphamide (1) · Gemcitabine (1) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1) · Papillomavirus Vaccines (1) · Vaccines, Synthetic (1)
Dana-Farber Cancer Institute (1) · Instituto Nacional de Salud Publica, Mexico (1) · Professor Fernando Figueira Integral Medicine Institute (1)
Brazil (1) · Mexico (1) · United States (1)
PMID 11398890, PMID 11886723, PMID 16585222, PMID 21166756, PMID 21444871, PMID 22137164, PMID 41276263